ConductScience.org, home

Paper1357461

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.

de Moraes JC and 9 others. Lancet, 1992. Cited by 307 papers, by iCite.

Cite this record

ConductScience Library. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Papers, record 1357461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1357461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.
PubMed
Journal
Lancet
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
307
iCite
Relative citation ratio, by iCite
10.4
iCite
Revised in PubMed
2019-06-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Moraes JCJ C
2Perkins BAB A
3Camargo MCM C
4Hidalgo NTN T
5Barbosa HAH A
6Sacchi CTC T
7Landgraf IMI M
8Gattas VLV L
9Vasconcelos Hde GH de G
10Gral IMI M

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial VaccinesMajor topic
Disease OutbreaksMajor topic
Meningococcal InfectionsMajor topic
VaccinationMajor topic
Adult
Bacterial Outer Membrane Proteins
Brazil
Case-Control Studies
Child
Child, Preschool
Female
Humans
Infant
Male
Meningococcal Vaccines
Neisseria meningitidis
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 307 citations.

PMIDTitleJournalYearIn PapersSource
42049314
Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: a double-blind randomised controlled human challenge study protocol.
BMJ Open2026https://conductscience.org/library/papers/42049314PubMed
39218947Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections.NPJ Vaccines2024https://conductscience.org/library/papers/39218947PubMed
38952055Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38952055PubMed
37585947Studies on the Child Handbook in Brazil: a scoping review.Rev Saude Publica2023https://conductscience.org/library/papers/37585947PubMed
37357142Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37357142PubMed
35246736Experimental Urethral Infection with Neisseria gonorrhoeae.Curr Top Microbiol Immunol2024https://conductscience.org/library/papers/35246736PubMed
35192786Product review on the IMD serogroup B vaccine Bexsero®.Hum Vaccin Immunother2022https://conductscience.org/library/papers/35192786PubMed
32681472Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data.Infect Dis Ther2020https://conductscience.org/library/papers/32681472PubMed
32037226Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.Vaccine2020https://conductscience.org/library/papers/32037226PubMed
31676919Continuous production of Neisseria meningitidis outer membrane vesicles.Appl Microbiol Biotechnol2019https://conductscience.org/library/papers/31676919PubMed
30838004Human Immune Responses and the Natural History of Neisseria gonorrhoeae Infection.Front Immunol2018https://conductscience.org/library/papers/30838004PubMed
29420119Cross-protection induced by VA-MENGOC-BC® vaccine.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29420119PubMed
29048985Impact of meningococcal group B OMV vaccines, beyond their brief.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29048985PubMed
27163398Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis.Hum Vaccin Immunother2016https://conductscience.org/library/papers/27163398PubMed
27111850Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.PLoS One2016https://conductscience.org/library/papers/27111850PubMed
26950303Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.PLoS One2016https://conductscience.org/library/papers/26950303PubMed
26744586
Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).
Can J Infect Dis Med Microbiol2015https://conductscience.org/library/papers/26744586PubMed
26466091FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.PLoS One2015https://conductscience.org/library/papers/26466091PubMed
25982025A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.J Infect2015https://conductscience.org/library/papers/25982025PubMed
25750999
Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.
Hum Vaccin Immunother2015https://conductscience.org/library/papers/25750999PubMed

See all 95 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1357461

GET https://conductscience.org/api/papers/v1/1357461/cited_by?page=2